About Affymetrix (NASDAQ:AFFX)
Affymetrix, Inc. (Affymetrix) is a provider of life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. The Company operates through two business segments: Affymetrix Core and eBioscience. The Affymetrix Core segment focuses on the development, manufacture and commercialization of systems for genetic analysis in the life sciences, agricultural biotechnology (AgBio) and diagnostic industry. The eBioscience segment primarily focuses on the development, manufacture, marketing and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses. The Company sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. It maintains sales and distribution operations across the United States, Europe, Latin America and Asia.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryLife Sciences Tools & Services
SectorN/A
SymbolNASDAQ:AFFX
CUSIP00826T10
Phone+1-408-7315000
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins4.24%
Return on Equity4.84%
Return on Assets2.97%
Miscellaneous
EmployeesN/A
Outstanding Shares80,490,000
Affymetrix (NASDAQ:AFFX) Frequently Asked Questions
What is Affymetrix's stock symbol?
Affymetrix trades on the NASDAQ under the ticker symbol "AFFX."
How were Affymetrix's earnings last quarter?
Affymetrix, Inc. (NASDAQ:AFFX) posted its earnings results on Wednesday, February, 17th. The scientific and technical instruments company reported $0.09 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.11 by $0.02. The scientific and technical instruments company had revenue of $95.60 million for the quarter, compared to analyst estimates of $93.29 million. Affymetrix had a return on equity of 4.84% and a net margin of 4.24%. During the same quarter in the prior year, the business posted $0.09 EPS. View Affymetrix's Earnings History.
Who are some of Affymetrix's key competitors?
Some companies that are related to Affymetrix include First Interstate BancSystem (FIBK), Renasant (RNST), Mimecast (MIME), Exponent (EXPO), Dorman Products (DORM), NovoCure (NVCR), Financial Engines (FNGN), United Natural Foods (UNFI), Bloomin' Brands (BLMN), Heron Therapeutics (HRTX), Global Blood Therapeutics (GBT), Allscripts (MDRX), Cogent Communications (CCOI), BlackLine (BL), The Advisory Board (ABCO), Portola Pharmaceuticals (PTLA), AnaptysBio (ANAB) and Mercury Systems (MRCY).
Has Affymetrix been receiving favorable news coverage?
News coverage about AFFX stock has been trending somewhat positive on Sunday, Accern reports. The research group identifies negative and positive news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Affymetrix earned a media sentiment score of 0.16 on Accern's scale. They also gave headlines about the scientific and technical instruments company an impact score of 47.19 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days.
How do I buy shares of Affymetrix?
Shares of AFFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Affymetrix's stock price today?
One share of AFFX stock can currently be purchased for approximately $14.01.
How big of a company is Affymetrix?
Affymetrix has a market capitalization of $1.13 billion.
How can I contact Affymetrix?
Affymetrix's mailing address is 3420 Central Expy, SANTA CLARA, CA 95051-0703, United States. The scientific and technical instruments company can be reached via phone at +1-408-7315000.
MarketBeat Community Rating for Affymetrix (AFFX)
MarketBeat's community ratings are surveys of what our community members think about Affymetrix and other stocks. Vote "Outperform" if you believe AFFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFFX will underperform the S&P 500 over the long term. You may vote once every thirty days.
Affymetrix (NASDAQ:AFFX) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 4/22/2016 forward)
Affymetrix (NASDAQ:AFFX) Earnings History and Estimates Chart
Affymetrix (NASDAQ AFFX) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 2/17/2016 | Q415 | $0.11 | $0.09 | $93.29 million | $95.60 million | View | N/A |  |
| 10/28/2015 | Q315 | $0.08 | $0.10 | $88.04 million | $86.50 million | View | Listen | |
| 7/29/2015 | Q215 | $0.07 | $0.12 | $88.61 million | $89.00 million | View | Listen | |
| 4/29/2015 | Q115 | $0.04 | $0.10 | $87.30 million | $88.70 million | View | Listen | |
| 2/4/2015 | Q414 | $0.07 | $0.09 | $91.80 million | $93.50 million | View | Listen | |
| 10/30/2014 | Q314 | $0.04 | $0.08 | $84.40 million | $87.10 million | View | Listen | |
| 7/31/2014 | Q214 | $0.03 | $0.07 | $83.30 million | $85.40 million | View | Listen | |
| 5/1/2014 | Q114 | $0.02 | $0.03 | $81.10 million | $83.00 million | View | Listen | |
| 2/5/2014 | Q413 | $0.07 | $0.02 | $89.98 million | $92.60 million | View | Listen | |
| 10/30/2013 | Q3 2013 | $0.02 | $0.05 | $78.85 million | $80.35 million | View | N/A | |
| 7/31/2013 | Q2 2013 | ($0.01) | $0.04 | $78.53 million | $79.46 million | View | Listen | |
| 4/30/2013 | Q1 2013 | ($0.02) | ($0.01) | $78.04 million | $77.90 million | View | Listen | |
| 1/31/2013 | Q4 2012 | ($0.03) | ($0.02) | $84.06 million | $84.40 million | View | Listen | |
| 11/5/2012 | Q312 | ($0.03) | ($0.03) | $84.56 million | $79.60 million | View | N/A | |
| 7/31/2012 | | ($0.08) | ($0.02) | | | View | N/A | |
| 5/3/2012 | | ($0.10) | ($0.06) | | | View | N/A | |
| 2/8/2012 | Q4 2011 | ($0.07) | ($0.21) | | | View | N/A | |
| 11/2/2011 | | ($0.04) | ($0.10) | | | View | N/A | |
| 7/27/2011 | | ($0.04) | ($0.05) | | | View | N/A | |
| 2/2/2011 | | $0.02 | $0.06 | | | View | N/A | |
| 10/27/2010 | Q3 2010 | ($0.06) | ($0.05) | | | View | N/A | |
| 7/21/2010 | Q2 2010 | ($0.07) | ($0.10) | | | View | N/A | |
| 4/21/2010 | Q1 2010 | ($0.09) | ($0.07) | | | View | N/A | |
| 2/3/2010 | Q4 2009 | ($0.10) | $0.04 | | | View | N/A | |
| 10/21/2009 | Q3 2009 | ($0.09) | ($0.13) | | | View | N/A | |
| 7/22/2009 | Q2 2009 | ($0.19) | ($0.13) | | | View | N/A | |
| 4/22/2009 | Q1 2009 | ($0.20) | ($0.34) | | | View | N/A | |
| 1/28/2009 | Q4 2008 | ($0.18) | ($0.95) | | | View | N/A | |
| 10/23/2008 | Q3 2008 | ($0.06) | ($0.17) | | | View | N/A | |
| 7/24/2008 | Q2 2008 | $0.05 | ($0.05) | | | View | N/A | |
| 4/24/2008 | Q1 2008 | | ($0.01) | | | View | N/A | |
| 1/31/2008 | Q4 2007 | $0.16 | $0.20 | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Affymetrix (NASDAQ:AFFX) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Affymetrix (NASDAQ AFFX) Insider Trading and Institutional Ownership History
Affymetrix (NASDAQ AFFX) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/15/2015 | Robert H Trice | Director | Sell | 2,500 | $9.40 | $23,500.00 | 47,278 | |
| 11/17/2015 | Robert H Trice | Director | Sell | 2,500 | $9.00 | $22,500.00 | 47,278 | |
| 10/15/2015 | Robert H Trice | Director | Sell | 2,500 | $9.00 | $22,500.00 | 47,278 | |
| 7/20/2015 | Frank Witney | CEO | Sell | 37,991 | $11.20 | $425,499.20 | | |
| 7/10/2015 | Frank Witney | CEO | Sell | 62,756 | $11.00 | $690,316.00 | | |
| 6/26/2015 | Frank Witney | CEO | Sell | 75,000 | $11.22 | $841,500.00 | | |
| 6/22/2015 | David A Weber | EVP | Sell | 33,879 | $12.00 | $406,548.00 | | |
| 6/19/2015 | David A Weber | EVP | Sell | 14,760 | $12.00 | $177,120.00 | | |
| 6/4/2015 | Frank Witney | CEO | Sell | 75,000 | $11.78 | $883,500.00 | | |
| 2/17/2015 | Gavin Wood | CFO | Sell | 1,300 | $11.40 | $14,820.00 | | |
| 1/20/2015 | Gavin Wood | CFO | Sell | 22,500 | $11.77 | $264,825.00 | | |
| 1/12/2015 | Gavin Wood | CFO | Sell | 10,200 | $10.77 | $109,854.00 | | |
| 12/29/2014 | Gavin Wood | CFO | Sell | 18,734 | $10.20 | $191,086.80 | | |
| 11/19/2013 | Robert Trice | Director | Sell | 6,205 | $7.98 | $49,515.90 | 53,199 | |
| 8/21/2012 | Timothy C Barabe | CFO | Buy | 10,000 | $3.75 | $37,500.00 | | |
| 8/17/2012 | Timothy C Barabe | CFO | Buy | 5,550 | $3.99 | $22,144.50 | | |
| 8/13/2012 | Timothy C Barabe | CFO | Buy | 4,450 | $3.99 | $17,755.50 | | |
(Data available from 1/1/2013 forward)
Affymetrix (NASDAQ AFFX) News Headlines
| Source: |
|
Affymetrix (NASDAQ:AFFX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Affymetrix (NASDAQ:AFFX) Income Statement, Balance Sheet and Cash Flow Statement
Affymetrix (NASDAQ AFFX) Stock Chart for Sunday, April, 22, 2018
Loading chart…
